drugset / Trial / NCT05613218

Oxygen Targets in Acute Heart Failure With Pulmonary Congestion

NCT05613218

RandomizedParallel-groupTriple-blindTreatment

Summary

This investigator-initiated, prospective, randomized, blinded, multi-center, controlled trial will investigate the effect of a restrictive vs. liberal oxygenation-strategy in patients hospitalized with acute heart failure with pulmonary congestion. Patients will be randomized 1:1 in the emergency department to either liberal or restrictive oxygenation after providing informed written consent. 1. Liberal oxygenation group = SpO2 target of 96%. 2. Restrictive oxygenation group = SpO2 target of 90%. The allocation will be concealed through the use of an oxygen-delivery robot, termed O2MATIC. The study will include 122 patients.

Timeline

Start
2024-02-01
Primary completion
2026-02-02
Completion
2026-03-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxygen Other / unclassified Inhaled